BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20133224)

  • 1. Potential etiopathogenesis of seventh day syndrome following living donor liver transplantation: ischemia of the graft?
    Lan X; Li B; Wang XF; Wei YG; Yan LN; Zhao JC
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):22-6. PubMed ID: 20133224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly defined clinical features and treatment experience of seventh day syndrome following living donor liver transplantation.
    Zhongwei Z; Lili C; Bo W; Xiaodong W; Goupeng L
    Transplant Proc; 2012 Mar; 44(2):494-9. PubMed ID: 22410054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of seventh-day syndrome following living donor liver transplantation.
    Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY
    Transplant Proc; 2006 Nov; 38(9):2961-3. PubMed ID: 17112874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and treatment of seventh day syndrome following living donor liver transplantation].
    Zhang ZW; Wang B; Yin WH; Deng LJ; Kang Y; Lu Q; Cao LL; Zhou Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):903-6. PubMed ID: 21302465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Abo T; Hatakeyama K
    Hepatogastroenterology; 2003; 50(54):2161-5. PubMed ID: 14696487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Oya H; Nakatsuka H; Kobayashi T; Watanabe T; Kameyama H; Hatakeyama K
    Hepatogastroenterology; 2003; 50(51):601-6. PubMed ID: 12828042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatofugal portal flow after living donor liver transplantation.
    Kyoden Y; Sugawara Y; Kaneko J; Kishi Y; Akamatsu N; Makuuchi M
    Hepatogastroenterology; 2007 Jun; 54(76):1164-6. PubMed ID: 17629062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live donor liver transplantation in high MELD score recipients.
    Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
    Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical progressive small-graft injury caused by intrasinusoidal pressure elevation following living donor liver transplantation.
    Sugimoto H; Kaneko T; Hirota M; Nagasaka T; Kobayashi T; Inoue S; Takeda S; Kiuchi T; Nakao A
    Transplant Proc; 2004 Nov; 36(9):2750-6. PubMed ID: 15621140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The delay of rearterialization after initial portal reperfusion in living donor liver transplantation significantly determines the development of microvascular graft dysfunction.
    Puhl G; Schaser KD; Pust D; Köhler K; Vollmar B; Menger MD; Neuhaus P; Settmacher U
    J Hepatol; 2004 Aug; 41(2):299-306. PubMed ID: 15288480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Middle hepatic treatment algorithm in right lobe living donor liver transplantation for donor recipient safety].
    Zhu ZJ; Hou JC; Zhang YM; Jiang WT; Yang T; Huai MS; Cai JZ; Wei L; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(26):1825-9. PubMed ID: 19953926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-center experience with retrograde reperfusion in liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Stadlbauer V; Tscheliessnigg KH
    Transpl Int; 2003 Oct; 16(10):730-5. PubMed ID: 12819865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in portal vein flow after adult living-donor liver transplantation: does it influence postoperative liver function?
    García-Valdecasas JC; Fuster J; Charco R; Bombuy E; Fondevila C; Ferrer J; Ayuso C; Taura P
    Liver Transpl; 2003 Jun; 9(6):564-9. PubMed ID: 12783396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pringle's maneuver and selective inflow occlusion in living donor liver hepatectomy.
    Imamura H; Kokudo N; Sugawara Y; Sano K; Kaneko J; Takayama T; Makuuchi M
    Liver Transpl; 2004 Jun; 10(6):771-8. PubMed ID: 15162472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterotopic liver transplantation in rats: effect of intrahepatic islet isografts and split portal blood flow on liver integrity after auxiliary liver isotransplantation.
    Yu W; Wan X; Wright JR; Coddington D; Bitter-Suermann H
    Surgery; 1994 Jan; 115(1):108-17. PubMed ID: 8284751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation.
    Deschênes M; Forbes C; Tchervenkov J; Barkun J; Metrakos P; Tector J; Alpert E
    Liver Transpl Surg; 1999 Sep; 5(5):357-61. PubMed ID: 10477834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for portal vein complications in pediatric living donor liver transplantation.
    Shibasaki S; Taniguchi M; Shimamura T; Suzuki T; Yamashita K; Wakayama K; Hirokata G; Ohta M; Kamiyama T; Matsushita M; Furukawa H; Todo S
    Clin Transplant; 2010; 24(4):550-6. PubMed ID: 19925458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival.
    Reese PP; Sonawane SB; Thomasson A; Yeh H; Markmann JF
    Transplantation; 2008 Jun; 85(12):1737-44. PubMed ID: 18580465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.